• No results found

5-ASA - colorectal cancer - cell death : an intriguing threesome Koelink, P.J.

N/A
N/A
Protected

Academic year: 2021

Share "5-ASA - colorectal cancer - cell death : an intriguing threesome Koelink, P.J."

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

5-ASA - colorectal cancer - cell death : an intriguing threesome

Koelink, P.J.

Citation

Koelink, P. J. (2010, January 14). 5-ASA - colorectal cancer - cell death : an intriguing threesome. Retrieved from https://hdl.handle.net/1887/14563

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/14563

Note: To cite this publication please use the final published version (if applicable).

(2)

5-ASA - Colorectal Cancer - Cell Death an intriguing threesome

Pim J. Koelink

(3)

5-ASA – Colorectal Cancer – Cell Death, an intriguing threesome Pim J. Koelink

Thesis, University of Leiden ISBN: 978-90-9024813-4

On cover (photograph and design by Pim J. Koelink):

Photomicropgraph of a colorectal cancer specimen stained for active caspase-3 (red) and M30 antigen (green).

Overlapping expression of these proteins shown in yellow. Nuclear material stained by Dapi (blue). Original magnification 1000 x.

Printed by Gildeprint Drukkerijen BV, Enschede, The Netherlands

© Pim J. Koelink 2009

All rights reserved. No part of this thesis may be reproduced or transmitted in any form, by any means, electronic or mechanical, without prior written permission of the author.

The printing of this thesis was financially supported by the Section Experimental Gastroenterology (SEG) of the Netherlands society of Gastroenterology (NVGE), Ferring Pharmaceuticals, Dr. Falk Pharma, Tramedico BV and Peviva BV.

(4)

5-ASA - Colorectal Cancer - Cell Death an intriguing threesome

PROEFSCHRIFT

ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus Prof. mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 14 januari 2010

klokke 15.00 uur

door

Pim Johan Koelink

geboren te Woerden in 1976

(5)

Promotiecommissie:

Promotores : Prof. dr. D.W. Hommes Prof. dr. C.B.H.W. Lamers

Co-promotor : Dr. ir. H.W. Verspaget

Overige leden : Prof. dr. J.H. Kleibeuker (Rijksuniversiteit Groningen) Prof. dr. H.J. van Krieken (Radboud Universiteit Nijmegen) Prof. dr. H.F. Vasen

Prof. dr. C.J. van de Velde

(6)

Contents

Page

Abbreviations 7/8

Chapter 1 9-28

General introduction and outline of the thesis

Chapter 2 29-46

Clinical significance of stromal apoptosis in colorectal cancer British Journal of Cancer 2009; 101(5):765-73

Chapter 3 47-66

Circulating cell death products predict clinical outcome of colorectal cancer patients BMC Cancer 2009; 9:88

Chapter 4 67-88

5-Aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cells death modes

Inflammatory Bowel Diseases 2009 Sep 22. [epub ahead of print].

Chapter 5 89-104

5-Aminosalicylic acid induces cell death in colorectal cancer cells in vitro and in vivo Submitted

Chapter 6 107-124

5-Aminosalicylic acid inhibits TGF-β1 signaling in colorectal cancer cells Cancer Letters 2009 Jun 19. [epub ehead of print].

Chapter 7 125-146

5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal cancer development in a novel conditional Apc mouse model

Carcinogenesis 2009;30(7):1217-24

(7)

Chapter 8 147-158 Radioprotection of colorectal cancer cells by 5-aminosalicylic acid

Chapter 9 159-166

Summarizing discussion

Chapter 10 167-174

Nederlandse samenvatting voor niet-ingewijden

List of publications 175

Curriculum Vitae 177

Nawoord 179

Full-colour illustrations 181-188

(8)

7

Abbreviations

5-ASA 5-aminosalicylic acid

α-SMA α-smooth muscle actin

ABC avidin-biotin complex

ALK-5 activin-receptor-like-kinase-5

APC adenomatous polyposis coli

BMP bone morphogenetic protein

BSA bovine serum albumin

caALK-5 constitutively active ALK-5

CD Crohn's Disease

COX cyclooxygenase

CRC colorectal cancer

DMEM Dulbeco’s Modified Eagle Medium

DMSO dimethyl sulfoxide;

ECM extracellular matrix

FAP familial adenomatous polyposis

FCS fetal calf serum

GAPDH glyceraldehyde phosphate dehydrogenase

GSK-3β ghlycogen synthase kinase-3β

H&E haematoxylin & eosin

HNPCC heriditary-non-polyposis-colorectal cancer

HRP horse-radish peroxidase

IBD inflammatory bowel disease

MMP matrix metalloproteinase

MMR mismatch repair

MIS microsatellite instability

NSAID non-steroidal-anti-inflammatory-drugs PAI-1 plasminogen activator inhibitor-1

PARP poly (ADP-ribose) polymerase

PBS phosphate buffered saline

PPARγ peroxisome proliferator-activated receptor-γ

RT room temperature

(9)

8

SDS sodium dodecyl sulphate

SP sulphapyridine

TCF-4 T-cell factor-4

TGF-β Transforming Growth Factor-β

TGF-βR Transforming Growth Factor-β-Receptor TUNEL TdT-mediated dUTP-biotin nick end-labeling

UC ulcerative colitis

Referenties

GERELATEERDE DOCUMENTEN

In the groups with high caspase- 3 activity the disease-free survival was found to be the best for patients with a high tumour caspase-3 activity and low M30 antigen level

For instance, docetaxel treatment increased levels of M30 antigen in the serum of breast cancer patients, indicating apoptotic death of tumour cells, while

The significant loss of total CK18 antigen levels in the post 5-ASA carcinoma biopsies indicates that 5-ASA caused the elimination of epithelial (cancer) cells within

5-ASA inhibited TGF- β1 signalling in HCT116 cells and colonic fibroblasts, as judged by a TGF-β- specific reporter gene assay, plasminogen activator inhibitor-1 mRNA and

In the first experiment the effect of 5-ASA was tested on DSS-induced colitis-associated neoplasia development in FabplCre;Apc 15lox/+ mice at 5 weeks of age,

In addition, 5-ASA treatment was found to increase the survival of mice subjected to lethal radiation doses, whereas the survival of irradiated animals with

The simultaneous decrease in CK18 levels in post-5-ASA biopsies, implicating a loss of epithelial cell content due to 5-ASA treatment, could well be the result of a

Dit geeft aan dat 5-ASA weldegelijk een toekomstige anti-darmkanker medicatie zou kunnen zijn, maar dat het niet in combinatie met bestralingstherapie gegeven moet